Vala MS - Search Results

1

Growth factor-mediated terminal differentiation of chronic myeloid leukemia.

Bedi A, Griffin CA, Barber JP, Vala MS, Hawkins AL, Sharkis SJ, Zehnbauer BA, Jones RJ. Bedi A, et al. Among authors: vala ms. Cancer Res. 1994 Nov 1;54(21):5535-8. Cancer Res. 1994. PMID: 7923192

2

The role of growth factors in the activity of pharmacological differentiation agents.

Matsui WH, Gladstone DE, Vala MS, Barber JP, Brodsky RA, Smith BD, Jones RJ. Matsui WH, et al. Among authors: vala ms. Cell Growth Differ. 2002 Jun;13(6):275-83. Cell Growth Differ. 2002. PMID: 12114217

3

Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.

Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith BD, Jones RJ. Angstreich GR, et al. Among authors: vala ms. Br J Haematol. 2005 Aug;130(3):373-81. doi: 10.1111/j.1365-2141.2005.05606.x. Br J Haematol. 2005. PMID: 16042686 Free article.

4

Characterization of chronic myeloid leukemia stem cells.

Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ. Gerber JM, et al. Among authors: vala ms. Am J Hematol. 2011 Jan;86(1):31-7. doi: 10.1002/ajh.21915. Am J Hematol. 2011. PMID: 21132730 Free PMC article.

5

BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ. Bedi A, et al. Among authors: vala ms. Blood. 1995 Aug 1;86(3):1148-58. Blood. 1995. PMID: 7620167 Free article.

6

Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation.

Matsui W, Huff CA, Vala M, Barber J, Smith BD, Jones RJ. Matsui W, et al. Br J Haematol. 2003 Apr;121(2):251-8. doi: 10.1046/j.1365-2141.2003.04255.x. Br J Haematol. 2003. PMID: 12694246 Free article.

7

Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations.

Gerber JM, Gucwa JL, Esopi D, Gurel M, Haffner MC, Vala M, Nelson WG, Jones RJ, Yegnasubramanian S. Gerber JM, et al. Oncotarget. 2013 May;4(5):715-28. doi: 10.18632/oncotarget.990. Oncotarget. 2013. PMID: 23651669 Free PMC article.

8

A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ. Gerber JM, et al. Among authors: vala ms. Blood. 2012 Apr 12;119(15):3571-7. doi: 10.1182/blood-2011-06-364182. Epub 2012 Jan 19. Blood. 2012. PMID: 22262762 Free PMC article.

9

Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity.

Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, Colvin OM, Sharkis SJ. Jones RJ, et al. Among authors: vala ms. Blood. 1996 Jul 15;88(2):487-91. Blood. 1996. PMID: 8695796 Free article.

10

Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.

Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ. Brodsky RA, et al. Among authors: vala ms. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8756-60. doi: 10.1073/pnas.94.16.8756. Proc Natl Acad Sci U S A. 1997. PMID: 9238050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters